Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02805546
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BMS![]() | A,B | 1DKF | 0.73 | ![]() | |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RU9 | 0.74 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUM | 0.74 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUL | 0.74 | ![]() |
4HT![]() | 4-HYDROXYTRYPTOPHAN | H,L | 1RUA | 0.74 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.73 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.73 | ![]() |
CEI![]() | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.73 | ![]() |
SAS![]() | 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID | A,B | 13GS | 0.77 | ![]() |
MSD![]() | 1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY- PHENYL)-CYCLOPROPYL]-3-(5-CYANO- PYRIDIN-2-YL)-THIOUREA | A | 1IKY | 0.76 | ![]() |
PT1![]() | PTEROIC ACID | A,B | 1TX0 | 0.74 | ![]() |
PT1![]() | PTEROIC ACID | A | 1BR6 | 0.74 | ![]() |
PT1![]() | PTEROIC ACID | A,B | 1HWP | 0.74 | ![]() |
I01![]() | (4R)-4-(2-FLUORO-6-HYDROXY-3-METHOXY- BENZOYL)-BENZOIC ACID (3R)-3-[(PYRIDINE- 4-CARBONYL)AMINO]-AZEPAN-4-YL ESTER | A | 1SVE | 0.71 | ![]() |
R96![]() | N-[4-({4-[5-(3,3-DIMETHYLPIPERIDIN- 1-YL)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH7 | 0.77 | ![]() |
LG2![]() | 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE- 3-CARBOXYLIC ACID | A,B,C,D | 1H9U | 0.73 | ![]() |
PXG![]() | 3-[O-PHOSPHONOPYRIDOXYL]--AMINO- BENZOIC ACID | A | 1B9I | 0.74 | ![]() |
VRS![]() | VIRGINIAMYCIN S1 | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YIT | 0.72 | ![]() |
I08![]() | (3R,4S)-N-(4-{TRANS-2-[4-(2-FLUORO- 6-HYDROXY-3-METHOXY-BENZOYL)-PHENYL]- VINYL}-AZEPAN-3-YL)-ISONICOTINAMIDE | A | 1SVH | 0.71 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 1K83 | 0.73 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L, M,T | 2VUM | 0.73 | ![]() |
TRX![]() | 6-HYDROXYTRYPTOPHAN | A,B,C,I,J,L,M | 3CQZ | 0.73 | ![]() |
D28![]() | 4-{[4-(4-fluoro-3-methylphenyl)- 1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid | A,B,C,D | 2VD1 | 0.75 | ![]() |
APT![]() | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.72 | ![]() |
R69![]() | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH4 | 0.78 | ![]() |
R69![]() | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH9 | 0.78 | ![]() |
HRP![]() | 5-HYDROXY-L-TRYPTOPHAN | B | 1YIA | 0.71 | ![]() |
S91![]() | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.7 | ![]() |
S91![]() | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.7 | ![]() |
D3E![]() | N-cyclopropyl-N-(trans-4-pyridin- 3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro- 1-hydroxy-1-methylethyl]benzamide | A,B,C,D | 3D3E | 0.71 | ![]() |
HQA![]() | 3-(8-hydroxyquinolin-3-yl)-L-alanine | A,B | 3FCA | 0.73 | ![]() |
PYU![]() | 2-(1H-pyrrol-1-ylcarbonyl)benzene- 1,3,5-triol | A,B | 3EKO | 0.73 | ![]() |
BP5![]() | 3-(2,2'-BIPYRIDIN-5-YL)-L-ALANINE | A | 2PXH | 0.7 | ![]() |
4PP![]() | C,L | 1XKA | 0.72 | ![]() | |
4PP![]() | A,B,C,D | 1XKB | 0.72 | ![]() | |
03R![]() | 2-({6-{3-[AMINO(IMINO)METHYL]PHENOXY}- 3,5-DIFLUORO-4-[(1-METHYL-3-PHENYLPROPYL)AMINO]- 2-PYRIDINYL}OXY)BENZOIC ACID | H,L | 2AEI | 0.72 | ![]() |
GIL![]() | 2-{[6-{3-[AMINO(IMINO)METHYL]PHENOXY}- 4-(DIISOPROPYLAMINO)-3,5-DIFLUOROPYRIDIN- 2-YL]OXY}-5-[(ISOBUTYLAMINO)CARBONYL]BENZOIC ACID | A,H,L,U | 2C4F | 0.7 | ![]() |
NFL![]() | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.74 | ![]() |
608![]() | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.7 | ![]() |
368![]() | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.71 | ![]() |
R55![]() | N-[4-({4-[5-(4,4-DIMETHYLPIPERIDIN- 1-YL)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH8 | 0.77 | ![]() |
BFU![]() | 1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6- FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)- CYCLOPROPYL]-UREA | A | 1EET | 0.75 | ![]() |
24X![]() | H,L | 2EC9 | 0.73 | ![]() | |
3HM![]() | 5-hydroxy-6-methylpyridine-3-carboxylic acid | A,B | 3GMC | 0.7 | ![]() |
R68![]() | N-{4-[(4-{3-[(2R)-3,3-DIMETHYLPIPERIDIN- 2-YL]-2-FLUORO-6-HYDROXYBENZOYL}BENZOYL)AMINO]AZEPAN- 3-YL}ISONICOTINAMIDE | A | 1XHA | 0.77 | ![]() |
R68![]() | N-{4-[(4-{3-[(2R)-3,3-DIMETHYLPIPERIDIN- 2-YL]-2-FLUORO-6-HYDROXYBENZOYL}BENZOYL)AMINO]AZEPAN- 3-YL}ISONICOTINAMIDE | A,B | 1XH5 | 0.77 | ![]() |
I04![]() | N-{(3R,4R)-4-[4-(2-FLUORO-6-HYDROXY- 3-METHOXY-BENZOYL)-BENZOYLAMINO]- AZEPAN-3-YL}ISONICOTINAMIDE | A | 1SVG | 0.72 | ![]() |
859![]() | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.78 | ![]() |
R94![]() | N-(4-{[4-(2-HYDROXY-5-PIPERIDIN- 1-YLBENZOYL)BENZOYL]AMINO}AZEPAN- 3-YL)ISONICOTINAMIDE | A | 1XH6 | 0.78 | ![]() |
NA4![]() | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.71 | ![]() |